Sign up for our weekly Newsletter!
  • 4x Blend

4x Blend

$26.99

498 in stock

Formulation 4x
GHRP-6 1.0mg
Ipamorelin 1.0mg
modGRF (1-29) 1.0mg
IGF-1Ec( Mechano Growth Factor) 500ug. In mammals, endogenous GH is released from the pituitary and regulated by the hypothalamic releasing and inhibiting hormones, such as GHRPs and GHRHs. The outcome is GH, a highly anabolic hormone that regulates protein synthesis, fat, metabolism and other processes.
Exogenous administration of GHRP/GHRH stimulates endogenous GH. The combined administration of them causes a significant rise in GH levels in vivo and vitro as opposed to a sole dose of either one. In one particular study, a cohort of elderly and young subjects was administered 1-10ug/kg of both GHRP and GHRH. Subject’s baseline IGF levels were approximately 90ug +/- 20ug/L (elderly) and 300ug +/- 50ug/L (young). The 30 day concluded results are a 3 fold endogenous secretion of GH and a substantial increase in IGF compared to day 0. These results were analyzed with other protocols that determined GHRP/GHRH synergy combination has greater overall effectiveness when used together than sole administration. ,
IGF-1 gene is capable of diverse mRNA transcripts. The IGF-1 mRNA codes different isoforms of IGF, including, IGF-1Ec or MGF. The current interpretation of MGF’s mechanism is based upon mechanical signals, such as pain from damaged muscle under extreme load. By linking this stimulus with mRNA transcription for gene expression, the affected areas will promote cellular differentiation and protein synthesis required for muscle repair. Additionally, IGF/GH circulates in targeted tissues and GH is utilized in muscle growth. This action creates IGF locally in tissues, in this case damaged muscle, which promotes the splice variant IGF-1Ec from the mRNA transcript. IGF is also created in the liver in a similar fashion with GH acting as a messenger. This comingling is the formation of the IGF/GH negative feedback system.

498 in stock

Product Description

Formulation 4x
GHRP-6 1.0mg
Ipamorelin 1.0mg
modGRF (1-29) 1.0mg
IGF-1Ec( Mechano Growth Factor) 500ug. In mammals, endogenous GH is released from the pituitary and regulated by the hypothalamic releasing and inhibiting hormones, such as GHRPs and GHRHs. The outcome is GH, a highly anabolic hormone that regulates protein synthesis, fat, metabolism and other processes.
Exogenous administration of GHRP/GHRH stimulates endogenous GH. The combined administration of them causes a significant rise in GH levels in vivo and vitro as opposed to a sole dose of either one. In one particular study, a cohort of elderly and young subjects was administered 1-10ug/kg of both GHRP and GHRH. Subject’s baseline IGF levels were approximately 90ug +/- 20ug/L (elderly) and 300ug +/- 50ug/L (young). The 30 day concluded results are a 3 fold endogenous secretion of GH and a substantial increase in IGF compared to day 0. These results were analyzed with other protocols that determined GHRP/GHRH synergy combination has greater overall effectiveness when used together than sole administration. ,
IGF-1 gene is capable of diverse mRNA transcripts. The IGF-1 mRNA codes different isoforms of IGF, including, IGF-1Ec or MGF. The current interpretation of MGF’s mechanism is based upon mechanical signals, such as pain from damaged muscle under extreme load. By linking this stimulus with mRNA transcription for gene expression, the affected areas will promote cellular differentiation and protein synthesis required for muscle repair. Additionally, IGF/GH circulates in targeted tissues and GH is utilized in muscle growth. This action creates IGF locally in tissues, in this case damaged muscle, which promotes the splice variant IGF-1Ec from the mRNA transcript. IGF is also created in the liver in a similar fashion with GH acting as a messenger. This comingling is the formation of the IGF/GH negative feedback system.